Sookja Kim Chung

Title: Sookja Kim Chung: Innovator in Neuroprotective Agents

Introduction

Sookja Kim Chung is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of neuroprotective agents, holding 2 patents that focus on innovative therapeutic solutions.

Latest Patents

One of his latest patents is a protective agent for retinal nerve or optic nerve. This invention provides a protective agent that operates through a different mechanism than conventional therapeutic agents, allowing for prolonged use. The protective agent comprises a compound with aldose reductase inhibiting activity, specifically a compound represented by a general formula. A preferable compound is (2S,4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide, where X can be a halogen atom or a hydrogen atom, and R1 and R2 can represent various alkyl groups or form a heterocycle with nitrogen or oxygen atoms.

Another significant patent involves novel heterodimers of tetrahydroacridines and tetrahydroquinolinones. These heterodimers act as both acetylcholinesterase inhibitors and N-methyl-D-aspartate (NMDA) receptor antagonists. They may be utilized to improve cognitive defects through treatment or prevention in both humans and non-humans.

Career Highlights

Sookja Kim Chung has worked with several prominent organizations, including Biotechnology Research Corporation Limited and Sanwa Kagaku Kenkyusho Co., Ltd. His work in these companies has contributed to advancements in biotechnology and neuropharmacology.

Collaborations

He has collaborated with notable individuals in his field, including Nancy Y Ip and Fanny Chui Fun Ip. These collaborations have further enhanced his research and development efforts.

Conclusion

Sookja Kim Chung is a distinguished inventor whose work in neuroprotective agents has the potential to significantly impact therapeutic practices. His innovative patents reflect a commitment to advancing medical science and improving cognitive health.